NASDAQ: DXCMDexcom Inc Stock Ownership - Who owns Dexcom?
Insider buying vs selling
Have Dexcom Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard Alexander Collins | Director | 2025-11-14 | 2,906 | $59.05 | $171.60kSell |
| Bridgette P. Heller | Director | 2025-11-12 | 1,012 | $58.07 | $58.77kSell |
| Jacob Steven Leach | President COO | 2025-11-10 | 15,700 | $54.98 | $863.14kBuy |
| Richard Alexander Collins | Director | 2025-11-10 | 3,948 | $55.17 | $217.81kSell |
| Jacob Steven Leach | President COO | 2025-11-10 | 2,500 | $55.43 | $138.56kBuy |
| Kyle Malady | Director | 2025-09-05 | 667 | $80.86 | $53.93kSell |
| Sadie Stern | EVP Chief HR Officer | 2025-09-04 | 1,466 | $80.00 | $117.28kSell |
| Jereme M. Sylvain | EVP Chief Financal Officer | 2025-09-02 | 4,824 | $74.17 | $357.80kSell |
| Mark G. Foletta | Director | 2025-08-15 | 195 | $81.54 | $15.90kSell |
| Mark G. Foletta | Director | 2025-08-15 | 2,555 | $81.02 | $207.00kSell |
DXCM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when DXCM insiders and whales buy or sell their stock.
DXCM Shareholders
What type of owners hold Dexcom Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Tudor Investment Corp Et Al | 17.73% | 69,150,000 | $4.53B | Institution |
| Vanguard Group Inc | 12.68% | 49,456,043 | $3.24B | Institution |
| Blackrock Inc | 9.95% | 38,821,843 | $2.54B | Institution |
| State Street Corp | 4.32% | 16,855,113 | $1.10B | Institution |
| Baillie Gifford Co | 4.07% | 15,882,168 | $1.04B | Institution |
| Geode Capital Management LLC | 2.81% | 10,963,772 | $718.02M | Institution |
| Jennison Associates LLC | 2.59% | 10,090,374 | $660.82M | Institution |
| Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC | 1.92% | 7,482,531 | $490.03M | Institution |
| Citadel Advisors LLC | 1.74% | 6,778,490 | $443.92M | Institution |
| Nuveen LLC | 1.63% | 6,343,476 | $415.43M | Institution |
DXCM vs Medical Device Stocks
Dexcom Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.